News ArchivesRead News

Northwestern Researchers Develop Milestone Parkinson's Treatment

Wednesday February 13, 2013

Ally Mutnick, Assistant Campus Editor

The Daily Northwestern - Northwestern researchers are continuing tests on their breakthrough development in the fight against Parkinson’s disease, a degenerative disorder that affects movement and coordination.

Toward the end of last year, chemistry Prof. Richard Silverman, and Dalton James Surmeier, chair of physiology at the Feinberg School of Medicine, created with their team a new family of compounds that could slow the progression of the disease.

So far, the compound has only been tested on animals, but experiments have produced successful results. However, researchers are now doing additional animal testing and working on turning the compound into a pill form, according to a Feb. 6 Chicago Tribune article.

The researchers believe their work can slow the disease without any serious side effects. Current treatment for Parkinson’s only targets the symptoms.

The new compound targets a rare faulty membrane protein that allows calcium to flood the dopamine neurons in the brain. These neurons control movement, and calcium interaction from Parkinson’s causes the cells to die, possibly leading to aging and premature death.

The researchers’ compound will selectively target the faulty protein and block calcium entry to stop cells from dying.

Surmeier and Silverman published their findings in the scientific journal Nature Communications on Oct. 23.

Recent News

Nov 22 - A caregiver's story: Living and loving through the slow process of dying
Nov 19 - Testosterone cause of sex differences in the occurrence of Parkinson’s disease, new research suggests
Nov 18 - New strategy reduces side effects in Parkinson's treatment
Nov 14 - Opinion: The never-ending tests of Parkinson's disease
Nov 13 - Parkinson’s disease: A new tool for diagnosis
Nov 10 - Parkinson's Disease Drug May Be Useful For Delaying, Preventing Blindness In Older Population
Nov 9 - Microsoft VP’s diagnosis fuels employees’ heartfelt efforts to help others
Nov 6 - Lewy body dementia: unrecognized and misdiagnosed
Nov 5 - Gait difficulties in Parkinson's linked to new blood vessels in brain
Oct 30 - Special Section: Enabling Technologies for Parkinson’s Disease Management
Oct 27 - Scientists discover a 'switchboard' of molecules that protect against Parkinson's disease
Oct 26 - Dancing improves mobility and quality of life in people with Parkinson's
Oct 23 - The amazing woman who can smell Parkinson’s disease — before symptoms appear
Oct 20 - Personal Essay: The deviousness of dementia
Oct 19 - Mechanism that 'melts' protein clumps may lead to new Parkinson's treatments
Oct 19 - Researchers find that stem cell treatment may reduce cognitive impairment related to dementia with Lewy bodies
Oct 17 - Cancer Drug Helps Parkinson's Patients
Oct 12 - Researchers identify immune gene that can prevent Parkinson's disease and dementia
Oct 12 - Blog Post: An Alert, Well-Hydrated Artist in No Acute Distress
Oct 7 - This month, a brain surgery will be broadcast on live TV for the first time ever